These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10166356)

  • 1. Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.
    Broussard LA; Hanson L
    Clin Lab Sci; 1997; 10(2):83-6. PubMed ID: 10166356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Abuscreen ONLINE assay for amphetamines on the Hitachi 737: comparison with EMIT and GC/MS methods.
    Baker DP; Murphy MS; Shepp PF; Royo VR; Caldarone ME; Escoto B; Salamone SJ
    J Forensic Sci; 1995 Jan; 40(1):108-12. PubMed ID: 7876791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
    Stout PR; Klette KL; Horn CK
    J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y; Ojanperä I; Rasanen I; Vuori E
    Forensic Sci Int; 2003 Jan; 131(2-3):148-55. PubMed ID: 12590054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEDIA for screening drugs of abuse in urine and the effect of adulterants.
    Wu AH; Forte E; Casella G; Sun K; Hemphill G; Foery R; Schanzenbach H
    J Forensic Sci; 1995 Jul; 40(4):614-8. PubMed ID: 7595298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
    Lachenmeier K; Musshoff F; Madea B
    Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method comparison of EMIT II and online with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Forensic Sci; 1993 Nov; 38(6):1326-41. PubMed ID: 8263477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
    Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
    Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary amphetamines, benzodiazepines and methadone: cost-effective detection procedures.
    Moore FM; Jarvie DR; Simpson D
    Med Lab Sci; 1992 Mar; 49(1):27-33. PubMed ID: 1453905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European multicentre evaluation of the analytical performance of the Abbott AxSYM Abused Drugs Assays.
    von Meyer L; Hänseler E; Lardet G; Scholer A; Sieghart W
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):133-40. PubMed ID: 9056758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
    Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
    J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phencyclidine and cannabinoids in vitreous humor.
    Jenkins AJ; Oblock J
    Leg Med (Tokyo); 2008 Jul; 10(4):201-3. PubMed ID: 18294895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of cross-reactivity of Ambien (zolpidem) with drugs in standard urine drug screens.
    Piergies AA; Sainati S; Roth-Schechter B
    Arch Pathol Lab Med; 1997 Apr; 121(4):392-4. PubMed ID: 9140309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.